Closing date: Thursday 12 September 2019
CheckUP is providing a health consumer representative with a unique opportunity to participate on an Advisory Group for the Primary Care – Genomics for GPs Initiative (the Initiative).
CheckUP is a not-for-profit organisation dedicated to better health for people and communities who need it most.
CheckUP has been funded by Queensland Genomics
to undertake a Primary Care – Genomics for GPs Initiative. The overall aim of the initiative to is ensure the General Practice workforce can incorporate genomics into everyday healthcare by confidently and accurately using genomic information in clinical decision making. CheckUP will work in partnership with Queensland Genomics, Queensland Primary Healthcare Network’s, The Royal Australian College of General Practitioners (RACGP) and a Genomics Primary Care Advisory Group to develop a GP engagement strategy, develop RACGP accredited education modules and deliver 6 workshops across Queensland that specifically target General Practitioners. Having a consumer involved in this process will be an integral role to inform and input into this initiative.
Consumers accessing genetic testing themselves online or via research studies or specialist services is becoming increasingly common. Primary care will be the first port of call for people who have received results concerning themselves or their relatives. Improvements in genomics education are needed to prepare primary care providers for the impact of ongoing rapid advances in genomics.
What is Genomics?
Genomics studies the unique genetic make-up of individuals and is set to revolutionise healthcare. It will lead to better prevention, prediction and diagnosis of disease, and improved treatment, management and cures. Genomics is an important emerging field in medicine that have increasing relevance and impact in general practice. Genomics plays a role in many conditions seen in primary care everyday including rare diseases and chronic conditions such as cancer and diabetes.
The key purpose of the Genomics Primary Care Advisory Group is to provide advice on the implementation of the GP engagement strategy and the content of the education modules.
The Advisory Group will:
- Provide advice and feedback on the education modules developed for GPs.
- Provide advice on the roll-out of the GP training workshops.
- Review and provide feedback on the GP Engagement Strategy.
- Put forward ideas and proposals to further support the integration of Genomics in General Practice in the future.
- Provide advice to Queensland Genomics Project Steering Group as required.
Membership of the Advisory Group will include representation from:
- Queensland Genomics
- General Practice
- Consumer Representative– Provided by Health Consumers Queensland
- Relevant Primary Health Networks
- Relevant Divisions of General Practice
- Other representatives as determined by Queensland Genomics
Role of the Consumer
The consumer representative on the Genomics Primary Care Advisory Group have the key role of adding the consumer/patient perspective to the project. It is important that GPs have an understanding of genomics from a patient perspective so that genomic information is appropriately used in clinical decision making, that informs the consumer.
The successful applicant is required to attend all Advisory Group meetings and to actively participate in all activities such as pre-meeting reading, discussions, provision of feedback and advice.
Who is this for?
This opportunity would suit a consumer representative with at least 6 months’ committee experience, either at the Hospital and Health Service, or Statewide level. An understanding of genomics would be ideal for the consumer representative. However, a consumer with an interest would also be suitable as CheckUP will ensure consumers receive the appropriate support to feel confident contributing to the project.
Time and location
Advisory Group members are asked to attend/participate in up to three meetings which will be held quarterly. The first meeting will take place in late September 2019 (date to be confirmed) with additional meeting dates to be scheduled. Advisory Group meetings will be held at CheckUP, Level 2/36, Russell Street, South Brisbane. A face to face meeting opportunity is available and travel costs will be covered for consumers who are based outside Brisbane. However, there is also an option to dial in via teleconference, if preferred.
Remuneration and support
Consumer representatives will be remunerated at $187.50 per meeting which includes pre-reading, travel time, expenses, and parking as well as travel costs. Morning/afternoon tea or lunch will be provided at the meetings.
Successful applicants will be given a background briefing via phone prior to the first meeting and will be supported by the CheckUP Business Coordinator should they require additional information and/or support to link with other group members.
How To Apply
Please complete this consumer application form and return to email@example.com by Thursday 12th September 2019.
For assistance please contact Health Consumers Queensland via firstname.lastname@example.org or by phone on 07 3012 9090.
For queries relating to the Genomics Primary Care Advisory Group please call Sabrina Kerr, Business Coordinator Tuesday- Wednesday on 07 3105 8309 or email@example.com.
*** We request that completed Expressions of Interest are sent only to Health Consumers Queensland **
Closing date: Close of business Thursday, 30 May 2019
Metro North Hospital and Health Service
This 3-day interactive workshop aims to prepare health professionals to successfully implement evidence into practice to improve patient and health service outcomes. We would like to have a consumer involved in the final day of this workshop (Thursday 13th June) to:
- Discuss their experience being involved in improving health service delivery and/or research
- Provide feedback on implementation projects presented by participants as part of an expert panel
This event is hosted by Metro North Hospital and Health Services. Our presenters are health professionals with expertise in implementation science from Royal Brisbane and Women’s Hospital, University of Adelaide, Flinders University and Queensland University of Technology.
Role of the Consumer
The consumer will be required to:
- Give a short presentation (approximately 5-10 minutes) to the audience of around 40 health professionals about their experience being involved in health service improvement and/or research, with the purpose of inspiring our audience to consider how they could involve consumers in their own projects. This may include what role the consumer had in the team, how they contributed to service development, implementation and/or evaluation, what challenges they experienced in doing this, and advice for how consumer involvement should be approached. This presentation will be part of a longer session titled “How do we involve consumers throughout the process”, presented by Jo Smethurst (HCQ) and clinician-researchers Adrienne Young and Liz Lynch.
- Give feedback to workshop participants on their projects as part of a panel discussion. The role of the consumer will be to ask questions about the projects presented which prompts presenters and the wider audience to think about consumer involvement. Other members of the panel include Scott Bell (Director of Research, Metro North Hospital and Health Service), Amanda Dines (health services manager, Metro North Hospital and Health Service) and Liza-Jane McBride (Chief Allied Health Officer, Queensland Health), who will be providing feedback from a management and research perspective.
Closing date: Close of business Thursday, 4 April 2019
The purpose of the Steering Partnership (the Partnership) is to provide advice to the Executive Co-sponsors of the Queensland Health (QH) program ‘Delivering Healthcare That Matters’ (DHTM): Low Benefit Care. This work aims to identify and realise opportunities to spend less and really do better for people in terms of health outcomes, more effective care and more personalised care, through a through a focus on low value care (LVC), also referred to as low benefit care, that is care that provides little or no benefit, may cause harm, or yields marginal benefits at a disproportionately high cost.
Evidence shows that current systems and processes may sometimes mean that patients receive tests and treatments that do not benefit them, often cause them inconvenience – including leading to further unnecessary interventions – and sometimes might actually cause them harm. The opportunity cost of expending scarce resources on low-benefit care means those resources are foregone and an opportunity to provide high value care is lost.
The principal functions of the Partnership are to:
- Advise and support on the development and delivery of a workplan to identify and realise opportunities to reduce the incidence of care to patients that provides little or no benefit, may cause harm, or yields marginal benefits at a disproportionately high cost
- Actively monitor progress against the workplan and provide advice and support to assist in addressing any barriers to workplan implementation
- Champion workplan activities that contribute to the program objectives
- Identify and promote opportunities to support adoption of the value concept across other programs in Rapid Response Areas 2&3
- Provide strategic advice to DoH, the Minister, and HHSs.
The Collaborative shall be chaired by a Project Clinical Champion or the Chief Executive Champion (or delegate). Membership comprises the ex officio of the following positions:
- Clinical Co-champion x 2
- Chief Executive Lead
- Deputy Director-General, Healthcare Purchasing and System Performance
- Deputy Director-General, Clinical Excellence Queensland
- Assistant Deputy Director-General and Chief Clinical Information Officer
- Subject Matter Experts x 3
- Chair, Queensland Clinical Senate
- Chair of Chairs, Statewide Clinical Networks
- Chair EDMS Forum
- Chief Executive Health Consumers Queensland
- Senior Director, Rapid Results Team
- Chair of Primary Health Network CE group
- Choosing Wisely Representative
- Health Consumers Queensland CEO
- Consumer/Carer Respresentative
Role of the Consumer
The role of the consumers will be to participate in the Committee’s activities, including the review of papers in advance and attendance at the scheduled meetings. Support will be provided to the participating consumers in an atmosphere of good faith. Consumers are encouraged to speak up and provide feedback and advice based on their lived experience of accessing the health system. Consumers will be supported and encouraged to do so.
Closing date: Close of business Wednesday, 17 April 2019
Mental Health and Alcohol and Other Drugs Brach
The Mental Health Alcohol and Other Drugs Statewide Clinical Network is recruiting one consumer and one carer to fill available roles on the Network membership. We are seeking expressions of interest from consumers and carers who have experience with Queensland Health mental health and/or alcohol and drug treatment services.
The Mental Health Alcohol and Other Drugs Statewide Clinical Network is one of more than 20 statewide clinical networks across Queensland Health. The Network is part of the Queensland Health statewide clinical leadership structure, and provides an opportunity for clinicians, senior leaders and consumer and carer representatives to engage in planning, priority setting, information sharing and system improvement in key areas.
The main aim of the Network is to contribute to high quality, safe and accessible care for consumers in Queensland Health mental health and alcohol and drug treatment services.
The Network funds or undertakes specific work in agreed priority areas. Current Network priority areas include care planning, integrating mental health and alcohol and drug treatment services, and reducing seclusion and restraint. The Network is also responsible for reviewing and providing feedback on relevant Queensland Health guidelines, models of service and other clinical and strategic documents.
The Network membership includes clinicians from a diverse range of mental health and alcohol and drug treatment services across Queensland, representatives from key Queensland Health stakeholder groups including peak training providers and Department of Health governance units, and consumer and carer representatives.
The Terms of Reference are currently being reviewed and updated, and will be provided as soon as available.
Role of the Consumer
Consumer and carer representatives participate in all Network business, including attendance at meetings, reviewing meeting papers in advance, and responding to out-of-session business via email. All members on the Network represent particular groups, such as consumers and carers, clinical professions, service types or statewide work units.
Your role will be to advocate for the interests of the group you are representing (consumers or carers) during Network activities. You will be encouraged and supported to speak up and provide feedback and advice based on:
- your own lived experience of accessing Queensland Health mental health and/or alcohol and drug treatment services as a consumer or as a carer
- feedback you receive from others with lived experience, such as through a consumer or carer group or forum that you may be part of.
Closing date: Close of business Wednesday, 1 May 2019
Queensland Clinical Senate
The Queensland Clinical Senate (QCS) represents clinicians from across the health system and provides strategic advice and leadership on system-wide issues affecting the quality, affordability and efficient delivery of patient care within Queensland. QCS connects clinicians to improve care.
QCS provide a structured forum for clinician and stakeholder consultation and communication on matters of strategic importance. They discuss, consult, examine the evidence, consider and formulate practical innovative recommendations in the context of clinical and operational best practice.
Clinical leadership is provided by developing strategies to safeguard and promote the delivery of high quality, safe and sustainable patient care.
Health and Wellbeing of the Workforce
Wellness and Performance – do you understand the links between staff wellness and patient care? What stops clinicians from doing their job well? How do we overcome these challenges?
Research shows that:
- the health and wellbeing of the clinical workforce is inextricably linked to patient outcomes
- healthcare professionals report higher levels of distress, dissatisfaction and sick days compared with other sectors.1
Clinicians, consumers and system managers from across Queensland will gather to discuss the issues and possible solutions to a healthier, safer and more productive workforce.
1. Brand, Sarah L et al. “Whole-system approaches to improving the health and wellbeing of healthcare workers: A systematic review” PloS one vol. 12,12 e0188418. 4 Dec. 2017, doi: 10.1371/journal.pone.0188418
Role of the Consumer
The Queensland Clinical Senate is looking to support 3 – 4 consumers to attend the 2-day forum starting Thursday the 9th of May in the evening and a full day on Friday the 10th of May. There is one speaking opportunity available in the form of a panel discussion.
The panel presentation will be about “Extreme Wellbeing”. This session will delve into the struggles and challenges of continuing to provide healthcare during extreme events (both natural, e.g. cyclones, floods, etc. and other mass casualty events) that significantly impact on a community, when the clinician themselves is part of that community. Panel members are to be confirmed, however the consumer perspective will ideally be around how they perceive the importance of clinician wellbeing in providing the standard of care expected by the community. The meeting will link back to how the wellbeing of clinicians impacts on quality and safety of care.
There will be several tablework sessions on Friday where the input of consumer representatives around the wellbeing of clinicians will be vital in ensuring well-rounded responses are developed.